Bank Of Commerce (ONC) Announces TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy Mar 4, 2025 06:19AM
TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy Mar 4, 2025 06:00AM
BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates Feb 27, 2025 06:00AM
BeiGene to Present at Upcoming Investor Conferences Feb 25, 2025 06:01AM
BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 Feb 13, 2025 06:01AM


Jan 6, 2025 02:00AM BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe
Dec 9, 2020 09:30AM Oncolytics and SOLTI Report Clinical Synergy of Pelareorep with Checkpoint Inhibitors at the 2020 San Antonio Breast Cancer Symposium
Nov 9, 2020 08:11AM Oncolytics Biotech (ONCY) and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at SITC
Nov 9, 2020 08:05AM Oncolytics Biotech® and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at The Society for Immunotherapy of Cancer Annual Meeting
Dec 20, 2018 07:45AM Oncimmune Signs Agreement with America’s Choice Provider Network to Expand Access to its Blood Tests for the Early Detection of Lung and Liver Cancers
Nov 27, 2018 12:38PM Oncimmune’s Early Lung Cancer Test Now Covered by MultiPlan